Europe's industry in a spin as it comes to terms with human tissue engineered product proposal
This article was originally published in Clinica
Executive Summary
The publication on May 10 of the European Commission's proposal for a regulation on advanced therapies has sent the medical devices sector into overdrive as industry associations, consultants and others grapple with the full implications of this text for human tissue engineered products (hTEPs), writes Amanda Maxwell.